Physician profile
Keith Getic
NPI 1710367453
$3,313.40
in general payments reported to CMS, 2019-2025
12 companies · $1,470 in 2025
The $1,470 reported for 2025 was more than what 88% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $33.87 · 2022: $326 · 2023: $612 · 2024: $871 · 2025: $1,470.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,953.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,953.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $1,252.25 | 2023-2025 | Dyanavel Xr |
| Corium, LLC | $1,120.70 | 2022-2025 | Azstarys |
| Abbvie INC. | $194.69 | 2025 | |
| Neos Therapeutics, Lp | $185.28 | 2023-2025 | Cotempla Xr-Odt, Adzenys Xr-Odt |
| Takeda Pharmaceuticals U.S.A., INC. | $170.05 | 2022-2025 | Trintellix |
| Vertical Pharmaceuticals, LLC | $91.52 | 2024-2025 | Relexxii |
| Supernus Pharmaceuticals, INC. | $74.57 | 2021-2022 | |
| Noven Therapeutics, LLC | $72.65 | 2024-2025 | Xelstrym |
| Lundbeck LLC | $50.17 | 2022-2023 | Rexulti |
| Ironshore Pharmaceuticals INC. | $37.64 | 2024 | |
| Collegium Pharmaceutical, INC. | $37.47 | 2025 | Jornay Pm |
| Axsome Therapeutics, INC. | $26.41 | 2023 | Auvelity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Getic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.